Sunshine Overseas: Transparency Rules For Life Sciences

Law360, New York (October 10, 2012, 2:14 PM EDT) -- In the wake of the U.S. Physician Payments Sunshine Act (signed into law in March 2010), European, Asian and Australian governmental bodies and trade associations have been rapidly adopting “Sunshine-like” transparency and disclosure requirements applicable to life sciences companies.

These new requirements vary in scope, rigor and reporting deadlines — creating a patchwork of international requirements — and present significant compliance challenges for life sciences companies that conduct ex-U.S. activities such as clinical trials and international advisory boards, among others.

For instance, in December 2011, France...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.